BACKGROUND: The current technique for locating nonpalpable breast lesions is wire localization (WL). Radioactive seed localization and intraoperative ultrasound were developed to improve difficulties with WL. The SAVI SCOUT surgical guidance system was developed to improve these methods. The SCOUT system is a non-radioactive, FDA-cleared medical device that uses electromagnetic wave technology to provide real-time guidance during excisional breast procedures. METHODS: Consenting patients underwent localization and excision using an implantable electromagnetic wave reflective device (reflector) and a detector handpiece with a console. Using image guidance, the reflector was placed up to 7 days before the surgical procedure. The primary end points of the study were successful reflector placement, localization, and retrieval. The secondary end points were percentage of clear margins, reexcision rates, days of placement before excision, and physician comparison with WL. RESULTS: This study analyzed 50 patients. The reflectors were placed under mammographic guidance (n = 18, 36 %) or ultrasound guidance (n = 32, 64 %). Of the 50 patients, 10 (20 %) underwent excisional biopsy and 40 (80 %) had a lumpectomy. The lesion and reflector were successfully removed in all 50 patients, and no adverse events occurred. Of the 41 patients who had in situ and/or invasive carcinoma identified, 38 (93 %) had clear margins and 3 (7 %) were recommended for reexcision. CONCLUSIONS: These data suggest that the SCOUT system is safe and effective for guiding the excision of nonpalpable breast lesions and a viable alternative to standard localization options. A larger prospective, multi-institution trial of SCOUT currently is underway to validate these findings.
BACKGROUND: The current technique for locating nonpalpable breast lesions is wire localization (WL). Radioactive seed localization and intraoperative ultrasound were developed to improve difficulties with WL. The SAVI SCOUT surgical guidance system was developed to improve these methods. The SCOUT system is a non-radioactive, FDA-cleared medical device that uses electromagnetic wave technology to provide real-time guidance during excisional breast procedures. METHODS: Consenting patients underwent localization and excision using an implantable electromagnetic wave reflective device (reflector) and a detector handpiece with a console. Using image guidance, the reflector was placed up to 7 days before the surgical procedure. The primary end points of the study were successful reflector placement, localization, and retrieval. The secondary end points were percentage of clear margins, reexcision rates, days of placement before excision, and physician comparison with WL. RESULTS: This study analyzed 50 patients. The reflectors were placed under mammographic guidance (n = 18, 36 %) or ultrasound guidance (n = 32, 64 %). Of the 50 patients, 10 (20 %) underwent excisional biopsy and 40 (80 %) had a lumpectomy. The lesion and reflector were successfully removed in all 50 patients, and no adverse events occurred. Of the 41 patients who had in situ and/or invasive carcinoma identified, 38 (93 %) had clear margins and 3 (7 %) were recommended for reexcision. CONCLUSIONS: These data suggest that the SCOUT system is safe and effective for guiding the excision of nonpalpable breast lesions and a viable alternative to standard localization options. A larger prospective, multi-institution trial of SCOUT currently is underway to validate these findings.
Authors: Hillary W Garner; Joseph M Bestic; Jeffrey J Peterson; Steven Attia; Daniel E Wessell Journal: Skeletal Radiol Date: 2016-11-24 Impact factor: 2.199
Authors: Winona L Richey; Jon S Heiselman; Ma Luo; Ingrid M Meszoely; Michael I Miga Journal: Int J Comput Assist Radiol Surg Date: 2021-08-12 Impact factor: 3.421
Authors: Umar Wazir; Salim Tayeh; Nicholas Perry; Michael Michell; Anmol Malhotra; Kefah Mokbel Journal: In Vivo Date: 2020 Jan-Feb Impact factor: 2.155
Authors: Gianluca Franceschini; Elena Jane Mason; Cristina Grippo; Sabatino D'Archi; Anna D'Angelo; Lorenzo Scardina; Alejandro Martin Sanchez; Marco Conti; Charlotte Trombadori; Daniela Andreina Terribile; Alba Di Leone; Beatrice Carnassale; Paolo Belli; Riccardo Manfredi; Riccardo Masetti Journal: J Pers Med Date: 2021-02-04
Authors: Aikaterini E Micha; Victoria Sinnett; Kate Downey; Steve Allen; Briony Bishop; Lauren R Hector; Elaine P Patrick; Ruth Edmonds; Peter A Barry; Katherine D C Krupa; Jennifer E Rusby Journal: Breast Cancer Date: 2020-09-24 Impact factor: 4.239